Grilled Cheese

ExploreLog inSign up

The Lancet Oncology

@thelancetoncol.bsky.social

51 Following1.1k Followers

The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.

🌐 https://www.thelancet.com/journals/lanonc/home

PostsRepliesMedia
@thelancetoncol.bsky.socialSep 29, 2026, 5:02 PM

🆕Our October issue is live!

📊Articles: #ovariancancer, #breastcancer, #multiplemyeloma, #prostatecancer, #lungcancer

📉Trials: KEYLYNK-001, CHN HYPOPMRT, SYMPRO-Lung trial, OPTIMUM/MUKnine, STAMINA

🎨Cover: Cancer & the microbiome

Read here: thelancet.com/issue/S1470-...

@thelancetoncol.bsky.socialSep 25, 2026, 9:10 AM

Just launched: Accelerating equitable cancer genomics and precision oncology in health care and research: a
@thelancetoncol.bsky.social Commission

With a new framework, implementation could be more equitable, effective, and sustainable

Read more: thelancet.com/commissions-...

@thelancet.comSep 25, 2026, 3:12 AMReposted by @thelancetoncol.bsky.social

Cancer genetic testing and precision oncology are advancing rapidly—but access is not.

A new @thelancetoncol.bsky.social Commission sets out how health systems can scale these innovations equitably and sustainably: spkl.io/633287TYKi #WCC2026

Lancet infographic containing four scatter graphs showing precision oncology research is predominantly in countries with higher income, not higher cancer deaths. Under the graphs are a microscope, money bag, and graduation cap with arrows pointing up next to them. The three images represent 'more research infrastructure', 'more industry investment', and 'more academic capcity', respectively, as the reasons for the imbalance.Lancet infographic containing an upside-down triangle graphic with four numbered sections. Next to the triangle is a table detailing a four-tier UHC framework for prioritising precision oncology interventions. The four tiers are Essential, Core expansion, Conditional, Evidence generation.Lancet infographic representing the practical context-sensitive instrument for health systems planners and policy makers accompanying a four-tier UHC framework for prioritising precision oncology interventions. In one circle, there is a traffic light on green representing 'A system-readiness tool'. In a second circle is a person, light bulb, and cog system representing 'A workforce competency framework. In a third circle, there is a bar graph with an eye in a magnifying glass in front of it representing 'A monitoring and evaluation framework'.
@thelancetoncol.bsky.socialSep 23, 2026, 4:01 PM

🚨Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial

📑Read here: thelancet.com/journals/lan...

📺Watch here: youtu.be/3OH_3uAj-xE?...

@thelancetoncol.bsky.socialSep 23, 2026, 2:49 PM

🔴Online now: Global health expenditures on cancer control: a cross-sectional analysis

"By making cancer expenditures visible and comparable, this work helps create an evidence base to inform priority setting and allocation decisions for cancer control."

thelancet.com/journals/lan...

@thelancetoncol.bsky.socialSep 18, 2026, 5:14 PM

Attending #WorldCancerCongress #WCC2026 in Hong Kong?

Join us for the launch of the new @thelancetoncol.bsky.social Commission on Accelerating equitable cancer genomics and precision oncology
Friday Sept 25, 2026 at 11:10 AM (Asia/Hong Kong)

@thelancetoncol.bsky.socialSep 15, 2026, 2:47 PM

🔴Online now: Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial

thelancet.com/journals/lan...

@thelancetoncol.bsky.socialSep 10, 2026, 8:38 AM

📽️Watch now: Unpicking the UK's cancer response after Brexit: what broke, what was patched up, and what still matters

Read the full Essay in @thelancetoncol.bsky.social

youtu.be/HIYHaqbK9UY?...

@thelancetoncol.bsky.socialSep 4, 2026, 9:02 AM

🎧Listen & subscribe to our Sept podcast:

Prof Sherene Loi and the International Immuno-Oncology Biomarker Working Group on TILs in breast cancer

Spotify: open.spotify.com/show/3JOj0Cl...

Apple: podcasts.apple.com/us/podcast/t...

Sept issue: www.thelancet.com/issue/S1470-...

@thelancetoncol.bsky.socialAug 28, 2026, 8:01 AM

Looking forward to this year's #WorldCancerCongress #WCC2026 where our Editor-in-Chief will be chairing three sessions including two on Commissions from @thelancetoncol.bsky.social and a Rapid Fire session on some of the latest research. See you in Hong Kong!

Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-12 04:31:30 EDT